Mangrove Partners »

Taysha Gene Therapies shares owned by Mangrove Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Mangrove Partners from 13F filings

Historical chart of Mangrove Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Mangrove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Mangrove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $113k 21k 5.50

More positions owned by Mangrove Partners

Indivior Ord
Rio Tinto Sponsored Adr (RIO)
Atmus Filtration Technologies Ord (ATMU)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ecovyst (ECVT)
Becton, Dickinson and (BDX)
Enova Intl (ENVA)
Flywire Corporation Com Vtg (FLYW)
Millrose Pptys Com Cl A (MRP)
PG&E Corporation (PCG)
Bio Rad Labs Cl A (BIO)
Bill Com Holdings Ord (BILL)
Elme Communities Sh Ben Int (ELME)
Fidelity National Information Services (FIS)
Rex American Resources (REX)

View all positions for Mangrove Partners

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies